Conference Coverage

Pop Quiz
Pop Quiz
05/20/2025
Anthony Calabro, MA
As surgical care evolves with the integration of risk calculators and biomarker-driven algorithms, it's tempting to rely heavily on these tools for clinical decisions. Yet, some elements of patient...
05/20/2025
AACE Conference Coverage
AACE Conference Coverage
05/20/2025
Daniel Drucker, OC, MD, FRCPC, FRSC, FRS
At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...
05/20/2025
AACE Conference Coverage
AACE Conference Coverage
05/20/2025
Daniel Drucker, OC, MD, FRCPC, FRSC, FRS
At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...
05/20/2025
AACE Conference Coverage
AACE Conference Coverage
05/20/2025
Daniel Drucker, OC, MD, FRCPC, FRSC, FRS
At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...
05/20/2025
AACE Conference Coverage
AACE Conference Coverage
05/20/2025
Daniel Drucker, OC, MD, FRCPC, FRSC, FRS
At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...
05/20/2025
SGO Conference Coverage
SGO Conference Coverage
05/20/2025
Kate Young
A new analysis of more than 42,000 cases reveals that uterine serous carcinoma is almost exclusively a postmenopausal disease, with less than 2% of cases diagnosed before age 52 — highlighting menopause,...
05/20/2025
SGO Conference Coverage
SGO Conference Coverage
05/20/2025
Kate Young
A new analysis of more than 42,000 cases reveals that uterine serous carcinoma is almost exclusively a postmenopausal disease, with less than 2% of cases diagnosed before age 52 — highlighting menopause,...
05/20/2025
SGO Conference Coverage
SGO Conference Coverage
05/20/2025
Kate Young
A new analysis of more than 42,000 cases reveals that uterine serous carcinoma is almost exclusively a postmenopausal disease, with less than 2% of cases diagnosed before age 52 — highlighting menopause,...
05/20/2025
SGO Conference Coverage
SGO Conference Coverage
05/20/2025
Kate Young
A new analysis of more than 42,000 cases reveals that uterine serous carcinoma is almost exclusively a postmenopausal disease, with less than 2% of cases diagnosed before age 52 — highlighting menopause,...
05/20/2025
SGO Conference Coverage
SGO Conference Coverage
05/20/2025
Kate Young
A new analysis of more than 42,000 cases reveals that uterine serous carcinoma is almost exclusively a postmenopausal disease, with less than 2% of cases diagnosed before age 52 — highlighting menopause,...
05/20/2025